Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Telmisartan (40mg) + Ramipril (2.5mg) Tablet
Therapeutic Category
Cardiology, Cardiovascular, Hypertension/ Blood Pressure
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Telbolife R Tablet containing Telmisartan and Ramipril is used for the management of hypertension and cardiovascular risk conditions. It helps control blood pressure and supports overall heart and vascular health.
Telmisartan works as an angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure, while Ramipril acts as an ACE inhibitor that further reduces vascular resistance and supports heart protection.
The tablet is widely prescribed in cardiology and general medicine practice for hypertension, high cardiovascular risk patients, and heart-related complications, leading to consistent prescription demand.
With the rising prevalence of lifestyle-related hypertension and growing demand for dual-mechanism antihypertensive therapies, this product offers strong business potential for retailers and distributors. Its established clinical efficacy, broad cardiovascular relevance, and steady market demand make it a reliable product for growth in the cardiac care segment.
Some patients may experience dizziness, low blood pressure, headache, fatigue, increased potassium levels, dry cough (more likely due to Ramipril), or kidney function changes. Rarely, severe allergic reactions, angioedema, or significant renal impairment may occur and require immediate medical attention.
Telbolife R Tablet is indicated for hypertension (high blood pressure), high cardiovascular risk patients, heart failure (in selected cases), and kidney protection in diabetic patients as prescribed by a healthcare professional. It helps lower blood pressure, improve heart efficiency, and reduce the risk of stroke and heart attack.
This medicine should be used strictly under medical supervision. Regular monitoring of blood pressure, kidney function, and potassium levels is recommended. Not recommended during pregnancy. Use cautiously in patients with kidney disease, liver impairment, or electrolyte imbalance. Avoid potassium supplements unless prescribed.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Telmisartan 20 mg Tablet
Composition : Telmisartan (40mg) Tablet
Composition : Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg
Composition : Telmisartan 80mg Tablet
Composition : Telmisartan 80mg + Amlodipine 5mg Tablet
Composition : Telmisartan (80mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) Tablet
Composition : Telmisartan 40mg + Amlodipine 5mg Tablet
Composition : Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Composition : Telmisartan (40mg) + Metoprolol Succinate (25mg) Tablet
Composition : Telmisartan (40mg) + Metoprolol Succinate (50mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Telmisartan 40mg + Ramipril 2.5mg Tablet has strong demand in the cardiology, hypertension management, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for hypertension and cardiovascular disorder management under medical supervision. Telmisartan 40mg is an angiotensin II receptor blocker (ARB) that helps control high blood pressure and supports cardiovascular health Ramipril 2.5mg is an ACE inhibitor that helps relax blood vessels and improve blood flow Commonly prescribed for hypertension, cardiovascular risk reduction, and long-term heart health management as determined by healthcare professionals The combination provides effective blood pressure control through complementary mechanisms of action Widely prescribed by cardiologists and general physicians for chronic cardiovascular care This strengthens a comprehensive cardiology and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Telmisartan 40mg + Ramipril 2.5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from steady prescription demand, long-term therapy usage, repeat monthly purchases, reliable supply chain support, and attractive margins in the cardiovascular care segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.